1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Respiratory Inhalers Market – by Product Type

1.3.2        North America Respiratory Inhalers Market – by Technology

1.3.3        North America Respiratory Inhalers Market – by Disease Indication

1.3.4        North America Respiratory Inhalers Market – by Country

2.           North America Respiratory Inhalers Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Respiratory Inhalers Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert’s Opinion

5.           North America Respiratory Inhalers Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Cases of Respiratory Disorders

5.1.2        Growing Adoption of Generic Inhalers

5.2         Market Restraints

5.2.1        Lack of Early Diagnosis and High Cost of Inhalers

5.3         Market Opportunities

5.3.1        Increasing Adoption of Smart Inhalers Technology

5.4         Future Trends

5.4.1        Increasing Product Development Activities

5.5         Impact Analysis

6.           Respiratory Inhalers Market – North America Analysis

6.1         North America Respiratory Inhalers Market Revenue Forecast and Analysis

7.           North America Respiratory Inhalers Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         North America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)

7.3         Dry Powder Inhalers

7.3.1        Overview

7.3.2        Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Multi-Dose Dry Powder Inhalers

7.3.3.1          Overview

7.3.3.2          Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Single Dose Dry Powder Inhalers

7.3.4.1          Overview

7.3.4.2          Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Metered Dose Inhalers

7.4.1        Overview

7.4.2        Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Pressured Metered Dose Inhalers

7.4.3.1          Overview

7.4.3.2          Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Connected Metered Dose Inhalers

7.4.4.1          Overview

7.4.4.2          Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Nebulizers

7.5.1        Overview

7.5.2        Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3        Compressed Air Nebulizers

7.5.3.1          Overview

7.5.3.2          Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4        Mesh Air Nebulizers

7.5.4.1          Overview

7.5.4.2          Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5        Ultrasonic Air Nebulizers

7.5.5.1          Overview

7.5.5.2          Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Respiratory Inhalers Market Analysis and Forecast to 2028 – by Technology

8.1         Overview

8.2         North America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)

8.3         Manually Operated Inhalers

8.3.1        Overview

8.3.2        Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Digitally Operated Inhalers

8.4.1        Overview

8.4.2        Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Respiratory Inhalers Market Analysis and Forecast to 2028 – by Disease Indication

9.1         Overview

9.2         North America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)

9.3         Asthma

9.3.1        Overview

9.3.2        Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.4         COPD

9.4.1        Overview

9.4.2        COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pulmonary Arterial Hypertension

9.5.1        Overview

9.5.2        Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Respiratory Inhalers Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     North America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.2     US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3     US: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.3.1       US: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.3.2       US: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)

10.1.3.3       US: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.4     US: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.5     US: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.5.1       Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.5.1.1       Overview

10.1.5.1.2       Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.5.1.3       Canada: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.5.1.3.1     Canada: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.5.1.3.2     Canada: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)

10.1.5.1.3.3     Canada: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.5.1.4       Canada: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.5.1.5       Canada: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.5.2       Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.5.2.1       Overview

10.1.5.2.2       Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.5.2.3       Mexico: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.5.2.3.1     Mexico: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.5.2.3.2     Mexico: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)

10.1.5.2.3.3     Mexico: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.5.2.4       Mexico: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.5.2.5       Mexico: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca Plc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Beximco Pharmaceuticals Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Boehringer Ingelheim International GmbH

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Cipla Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      GSK Plc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips NV

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      OMRON Corp

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      PARI Respiratory Equipment, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Teva Pharmaceutical Industries Ltd

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   OPKO Health, Inc

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 6.             US Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Canada Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)

Table 14.          Mexico Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Mexico Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Recent Inorganic Growth Strategies

Table 20.          Recent Organic Growth Strategies

Table 21.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Respiratory Inhalers Market Segmentation

Figure 2.           North America Respiratory Inhalers Market, by Country

Figure 3.           North America Respiratory Inhalers Market Overview

Figure 4.           North America Respiratory Inhalers Market, By Product

Figure 5.           North America Respiratory Inhalers Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           North America Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America Respiratory Inhalers Market – Revenue Forecast and Analysis

Figure 10.        North America Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)

Figure 11.        Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Multi-Dose Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Single Dose Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Pressured Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Connected Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Compressed Air Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Mesh Air Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Ultrasonic Air Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Respiratory Inhalers Market, by Technology 2021 & 2028 (%)

Figure 22.        Manually Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)

Figure 25.        Asthma: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        COPD: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Pulmonary Arterial Hypertension: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Others: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        North America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)

Figure 30.        US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)